Literature DB >> 28320990

Comorbidities and Complications in Nonagenarians Undergoing Coronary Angiography and Intervention.

Mohamed Gayed1, Nour Yadak, Waad Qamhia, Yunis Daralammouri, Marc-Alexander Ohlow.   

Abstract

Elderly people represent the fastest growing portion of cardiovascular patients. We aimed to analyze the clinical presentation, risk factors, co-morbidities, complications, and mortality in patients 90 years or more who underwent coronary angiography and intervention.We retrospectively studied 108 (0.25% of 43,385) consecutive patients ≥ 90 years undergoing cardiac catheterization and/or intervention in a tertiary specialist hospital between 2003 and 2014.Most patients (68.5%) were introduced on an emergency basis, especially with acute coronary syndrome (ACS) (63.8%). Non-STEMI accounted for two-thirds of the myocardial infarctions. We found higher prevalences of previous coronary artery disease (CAD) (38%), other atherosclerotic diseases (20.4%), cardiac risk factors such as hypertension (84.3%), diabetes (49.1%), hyperlipidemia (50.9%), heart failure (42.6%), atrial fibrillation (AF) (25.0%), severe aortic stenosis (13.0%), severe mitral regurgitation (3.7%), and implantable devices (25.0%), and co-morbidities such as renal impairment (48.1%), COPD (12.0%), and previous stroke (6.5%). Three-vessel disease was present in 34.6% of the patients. The left anterior descending artery (LAD) was the most affected coronary artery (67.6%). Percutaneous coronary intervention (PCI), mostly with bare metal stents (BMS), was used to manage 54.6% of the patients, and it failed in 4 of the patients. Conservative treatment was used in 39.8% of the patients and 15.7% had no significant CAD.The incidences of vascular complications, such as bleeding (6.5%), bleeding in other organs (6.5%), blood transfusion (6.5%), in-hospital paroxysmal atrial fibrillation (7.4%), in-hospital successful reanimation (2.8%), complete heart block (5.6%), acute renal impairment (23.1%), associated infection (25.9%), cardiogenic shock (14.8%), and death (15.7%) were high.Considering the more extensive risk factors, CAD and co-morbidities, acute presentation and age per se, we believe that the reported higher rates of complications and mortality are still acceptable.

Entities:  

Mesh:

Year:  2017        PMID: 28320990     DOI: 10.1536/ihj.16-083

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  3 in total

1.  Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry).

Authors:  Yohei Numasawa; Taku Inohara; Hideki Ishii; Kyohei Yamaji; Shun Kohsaka; Mitsuaki Sawano; Masaki Kodaira; Shiro Uemura; Kazushige Kadota; Tetsuya Amano; Masato Nakamura
Journal:  J Am Heart Assoc       Date:  2019-03-05       Impact factor: 5.501

2.  Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow.

Authors:  Yuan-Ting Zhu; Ling-Ping Zhu; Zhen-Yu Wang; Xue-Ting Qiu; Wan-Zhou Wu; Wei-Wang Liu; Yu-Yu Feng; Wen-Kai Xiao; Xin Luo; Zhen-Yu Li; Chuan-Chang Li
Journal:  Cardiol Res Pract       Date:  2020-01-25       Impact factor: 1.866

3.  Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions.

Authors:  Rafał Januszek; Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Dariusz Dudek; Stanisław Bartuś
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.